(Q37869389)

24 August 2017

Oral antibiotic treatment and long-term outcomes of Lyme facial nerve palsy (English)

1 reference

24 August 2017

0 references

Michelle A. Mathiason

series ordinal

3

1 reference

24 August 2017

T J Kowalski

1

1 reference

24 August 2017

W L Berth

series ordinal

2

1 reference

24 August 2017

W A Agger

series ordinal

4

1 reference

24 August 2017

language of work or name

1 reference

27 April 2011

1 reference

24 August 2017

1 reference

24 August 2017

39

1 reference

24 August 2017

3

1 reference

24 August 2017

239-245

1 reference

https://scigraph.springernature.com/pub.10.1007/s15010-011-0107-7

24 August 2017

0 references

cites work

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Isolation of Borrelia burgdorferi sensu lato from blood of adult patients with borrelial lymphocytoma, Lyme neuroborreliosis, Lyme arthritis and acrodermatitis chronica atrophicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Evaluation of central nervous system involvement in Lyme borreliosis patients with a solitary erythema migrans lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

A Critical Appraisal of “Chronic Lyme Disease”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Evidence-based guidelines for the management of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Antibiotic treatment duration and long-term outcomes of patients with early lyme disease from a lyme disease-hyperendemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Understanding and identifying bias and confounding in the medical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Evaluation of study patients with Lyme disease, 10-20-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Subjective symptoms after treatment of early Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0107-7

Brief communication: hematogenous dissemination in early Lyme disease

21 January 2018

1 reference

12 December 2020

Diagnostic value of cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis

1 reference

12 December 2020

Adverse effects of minocycline versus doxycycline in the treatment of Lyme neuroborreliosis

1 reference

12 December 2020

Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria.

1 reference

12 December 2020

Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid

1 reference

12 December 2020

Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection

1 reference

12 December 2020

Response to meta-analysis of Lyme borreliosis symptoms

1 reference

12 December 2020

Acute transverse myelitis in Lyme neuroborreliosis

1 reference

12 December 2020

Lyme disease: clinical features, classification, and epidemiology in the upper midwest

1 reference

12 December 2020

[Peripheral facial paralysis? Exclude borreliosis, perform LP!]

1 reference

12 December 2020

Successful Oral Doxycycline Treatment of Lyme Disease‐Associated Facial Palsy and Meningitis

1 reference

12 December 2020

Successful treatment of neuroborreliosis with ten day regimens

1 reference

12 December 2020

Lyme disease and facial nerve palsy

1 reference

12 December 2020

Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease

1 reference

12 December 2020

10.1007/S15010-011-0107-7

Identifiers

DOI

1 reference

24 August 2017

1 reference